Cargando…

Neutralizing antibodies against EBV gp42 show potent in vivo protection and define novel epitopes

Epstein–Barr virus (EBV) is the first reported human oncogenic virus and infects more than 95% of the human population worldwide. EBV latent infection in B lymphocytes is essential for viral persistence. Glycoprotein gp42 is an indispensable member of the triggering complex for EBV entry into B cell...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Qian, Zhong, Ling, Wei, Dongmei, Zhang, Wanlin, Hong, Junping, Kang, Yinfeng, Chen, Kaiyun, Huang, Yang, Zheng, Qingbing, Xu, Miao, Zeng, Mu-Sheng, Zeng, Yi-Xin, Xia, Ningshao, Zhao, Qinjian, Krummenacher, Claude, Chen, Yixin, Zhang, Xiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10443957/ https://www.ncbi.nlm.nih.gov/pubmed/37542379 http://dx.doi.org/10.1080/22221751.2023.2245920

Ejemplares similares

Antibody Generation and Immunogenicity Analysis of EBV gp42 N-Terminal Region
por: Hong, Junping, et al.
Publicado: (2021)

Non-overlapping epitopes on the gHgL-gp42 complex for the rational design of a triple-antibody cocktail against EBV infection
por: Hong, Junping, et al.
Publicado: (2023)

Glycoprotein B Antibodies Completely Neutralize EBV Infection of B Cells
por: Hong, Junping, et al.
Publicado: (2022)

A novel vaccine candidate based on chimeric virus-like particle displaying multiple conserved epitope peptides induced neutralizing antibodies against EBV infection
por: Zhang, Xiao, et al.
Publicado: (2020)

Dose-Dependent Outcome of EBV Infection of Humanized Mice Based on Green Raji Unit (GRU) Doses
por: Chen, Haiwen, et al.
Publicado: (2021)

Protective anti-gB neutralizing antibodies targeting two vulnerable sites for EBV-cell membrane fusion
por: Zhang, Xiao, et al.
Publicado: (2022)

Designing and overproducing a tandem epitope of gp350/220 that shows a potential to become an EBV vaccine
por: Widodo, et al.
Publicado: (2018)

A high-throughput neutralizing assay for antibodies and sera evaluation against Epstein-Barr virus
por: Zhong, Ling, et al.
Publicado: (2022)

Urgency and necessity of Epstein-Barr virus prophylactic vaccines
por: Zhong, Ling, et al.
Publicado: (2022)

Immunization With Fc-Based Recombinant Epstein–Barr Virus gp350 Elicits Potent Neutralizing Humoral Immune Response in a BALB/c Mice Model
por: Zhao, Bingchun, et al.
Publicado: (2018)

Rabbit Monoclonal Antibody Specifically Recognizing a Linear Epitope in the RBD of SARS-CoV-2 Spike Protein
por: Hong, Junping, et al.
Publicado: (2021)

Super Potent Bispecific Llama VHH Antibodies Neutralize HIV via a Combination of gp41 and gp120 Epitopes
por: Strokappe, Nika M., et al.
Publicado: (2019)

Structural Basis for Epitopes in the gp120 Cluster A Region that Invokes Potent Effector Cell Activity
por: Tolbert, William D., et al.
Publicado: (2019)

Clinical analysis of 42 cases of EBV-positive mature T/NK-cell neoplasms
por: Yang, Haiyan, et al.
Publicado: (2017)

Reverse Immunology Approach to Define a New HIV-gp41-Neutralizing Epitope
por: Dorgham, Karim, et al.
Publicado: (2019)

Development of an Improved Epstein-Barr Virus (EBV) Neutralizing Antibody Assay to Facilitate Development of a Prophylactic gp350-Subunit EBV Vaccine
por: Liu, Hui, et al.
Publicado: (2020)

Capsid destabilization and epitope alterations of human papillomavirus 18 in the presence of thimerosal
por: Huang, Xiaofen, et al.
Publicado: (2021)

Protection against Lethal Enterovirus 71 Challenge in Mice by a Recombinant Vaccine Candidate Containing a Broadly Cross-Neutralizing Epitope within the VP2 EF Loop
por: Xu, Longfa, et al.
Publicado: (2014)

T = 4 Icosahedral HIV-1 Capsid As an Immunogenic Vector for HIV-1 V3 Loop Epitope Display
por: Zhang, Zhiqing, et al.
Publicado: (2018)

Increased frequency of T cells specific for EBV gp110 in the synovial fluid of patients with rheumatoid arthritis
por: Toussirot, E, et al.
Publicado: (2003)

Personalized adoptive immunotherapy for patients with EBV-associated tumors and complications: Evaluation of novel naturally processed and presented EBV-derived T-cell epitopes
por: Bieling, Maren, et al.
Publicado: (2017)

A human monoclonal antibody against HPV16 recognizes an immunodominant and neutralizing epitope partially overlapping with that of H16.V5
por: Xia, Lin, et al.
Publicado: (2016)

Characterization and immunogenicity of SARS-CoV-2 spike proteins with varied glycosylation
por: Deng, Tingting, et al.
Publicado: (2022)

A stepwise docking molecular dynamics approach for simulating antibody recognition with substantial conformational changes
por: Huang, Yang, et al.
Publicado: (2022)

The Anti-Apoptotic Role of EBV-LMP1 in Lymphoma Cells
por: Zeng, Mei, et al.
Publicado: (2020)

Identification and characterization of novel B-cell epitopes within EBV latent membrane protein 2 (LMP2)
por: Xue, Xiangyang, et al.
Publicado: (2011)

Vasculogenic mimicry formation in EBV-associated epithelial malignancies
por: Xiang, Tong, et al.
Publicado: (2018)

N(6)‐methyladenosine‐binding protein YTHDF1 suppresses EBV replication and promotes EBV RNA decay
por: Xia, Tian‐Liang, et al.
Publicado: (2021)

Bispecific Anti-HIV Immunoadhesins That Bind Gp120 and Gp41 Have Broad and Potent HIV-Neutralizing Activity
por: Pincus, Seth H., et al.
Publicado: (2021)

Structural definition of a conserved neutralization epitope on HIV-1 gp120
por: Zhou, Tongqing, et al.
Publicado: (2007)

Enhancing Exposure of HIV-1 Neutralization Epitopes through Mutations in gp41
por: Blish, Catherine A, et al.
Publicado: (2008)

Structure of a Complex Phosphoglycan Epitope from gp72 of Trypanosoma cruzi
por: Allen, Simon, et al.
Publicado: (2013)

Patterns of conserved gp120 epitope presentation on attached HIV-1 virions
por: Mengistu, Meron, et al.
Publicado: (2017)

EBV miRNAs are potent effectors of tumor cell transcriptome remodeling in promoting immune escape
por: Ungerleider, Nathan, et al.
Publicado: (2021)

Novel EBV LMP-2-affibody and affitoxin in molecular imaging and targeted therapy of nasopharyngeal carcinoma
por: Zhu, Shanli, et al.
Publicado: (2020)

An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3)
Publicado: (1990)

Broadly Reactive Human CD8 T Cells that Recognize an Epitope Conserved between VZV, HSV and EBV
por: Chiu, Christopher, et al.
Publicado: (2014)

Molecular and functional analysis of monoclonal antibodies in support of biologics development
por: Wang, Xin, et al.
Publicado: (2017)

Molecular basis for epitope recognition by non-neutralizing anti-gp41 antibody F240
por: Gohain, Neelakshi, et al.
Publicado: (2016)

COVID-19 vaccines based on viral nanoparticles displaying a conserved B-cell epitope show potent immunogenicity and a long-lasting antibody response
por: Affonso de Oliveira, Jessica Fernanda, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jrud7n618a5auem386tlkfov1h